CNBX Pharmaceuticals Inc. (CNBX)

Market Cap	112.58K -52.4%
Revenue (ttm)	n/a
Net Income	-393.34K
EPS	-0.00
Shares Out	1.13B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,581,466
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0113
Beta	-0.32
RSI	25.24
Earnings Date	Apr 15, 2026

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc., a clinical-stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug candidates, including PLP-33 for the local treatment of lateral spreading, or sessile, colorectal polyps during colonoscopy, BRST-33 for the treatment...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNBX